Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group’s CEO, Shawn Patrick O’Brien, is set to present at the 2024 Jefferies Global Healthcare Conference in New York on June 6. The company, known for its specialty pharmaceuticals and innovative oral drug delivery systems, will share insights into their operations and offerings. Interested parties can access the presentation via webcast, with further information available through Mayne Pharma’s Australian and US contact representatives.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
